These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

61 related items for PubMed ID: 174048

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Immunity to herpes simplex virus type 2. Suppression of virus-induced immune responses in ultraviolet B-irradiated mice.
    Yasumoto S, Hayashi Y, Aurelian L.
    J Immunol; 1987 Oct 15; 139(8):2788-93. PubMed ID: 2821119
    [Abstract] [Full Text] [Related]

  • 4. An investigation into the relationship of the immunological status of Herpes simplex virus type-2 (HSV-2) infected animals and the tumor-enhancing property of this infection.
    Reiss-Gutfreund RJ, Dostal V, Fanta D.
    Osterr Z Onkol; 1977 Oct 20; 4(2-3):35-9. PubMed ID: 201898
    [Abstract] [Full Text] [Related]

  • 5. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. II. Bifunctional clones with cytotoxic and virus-induced proliferative activities exhibit herpes simplex virus type 1 and 2 specific or type common reactivities.
    Yasukawa M, Zarling JM.
    J Immunol; 1984 Nov 20; 133(5):2736-42. PubMed ID: 6207243
    [Abstract] [Full Text] [Related]

  • 6. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
    Jacobs A, Tjuvajev JG, Dubrovin M, Akhurst T, Balatoni J, Beattie B, Joshi R, Finn R, Larson SM, Herrlinger U, Pechan PA, Chiocca EA, Breakefield XO, Blasberg RG.
    Cancer Res; 2001 Apr 01; 61(7):2983-95. PubMed ID: 11306477
    [Abstract] [Full Text] [Related]

  • 7. Reversal of virus-induced immune suppression.
    Strayer DS, Leibowitz JL.
    J Immunol; 1986 Apr 01; 136(7):2649-53. PubMed ID: 3005416
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Protection of neonatal mice against herpes simplex virus infection: probable in vivo antibody-dependent cellular cytotoxicity.
    Kohl S, Loo LS.
    J Immunol; 1982 Jul 01; 129(1):370-6. PubMed ID: 6282968
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Augmentation of immunity to herpes simplex virus by in vivo administration of interleukin 2.
    Rouse BT, Miller LS, Turtinen L, Moore RN.
    J Immunol; 1985 Feb 01; 134(2):926-30. PubMed ID: 2981270
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Adoptively transferred tumor-specific T cells stimulated ex vivo using herpes simplex virus amplicons encoding 4-1BBL persist in the host and show antitumor activity in vivo.
    Yi KH, Nechushtan H, Bowers WJ, Walker GR, Zhang Y, Pham DG, Podack ER, Federoff HJ, Tolba KA, Rosenblatt JD.
    Cancer Res; 2007 Oct 15; 67(20):10027-37. PubMed ID: 17942937
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Transfer of immunity by transfer of bone marrow cells: a requirement for T lymphocytes and sensitivity to cyclophosphamide.
    Marusić M.
    Exp Hematol; 1978 Oct 15; 6(9):725-37. PubMed ID: 361429
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Modulation of lymphoproliferation and oxidative burst by herpes-transformed tumors.
    Gridley DS, Das MR, Lau BH, Kettering JD.
    Mol Biother; 1991 Jun 15; 3(2):88-94. PubMed ID: 1654931
    [Abstract] [Full Text] [Related]

  • 20. Pre-existing herpes simplex virus 1 (HSV-1) immunity decreases, but does not abolish, gene transfer to experimental brain tumors by a HSV-1 vector.
    Herrlinger U, Kramm CM, Aboody-Guterman KS, Silver JS, Ikeda K, Johnston KM, Pechan PA, Barth RF, Finkelstein D, Chiocca EA, Louis DN, Breakefield XO.
    Gene Ther; 1998 Jun 15; 5(6):809-19. PubMed ID: 9747461
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.